Assessment of Fluoxetine's Effect in Patients With Multiple System Atrophy : a Double Blind Placebo-controlled Randomized Trial
Phase of Trial: Phase II
Latest Information Update: 01 Apr 2015
At a glance
- Drugs Fluoxetine (Primary)
- Indications Multiple system atrophy
- Focus Therapeutic Use
- Acronyms MSA-Fluox
- 11 Sep 2012 Preliminary results presented at the 16th Congress of the European Federation of Neurological Societies.
- 29 Feb 2012 Status changed from recruiting to completed, as reported by ClinicalTrials.gov.
- 29 Aug 2011 New trial record